Two-year PANORAMA results affirm aflibercept efficacy for nonproliferative diabetic retinopathy

Two-year results of the PANORAMA study show consistently better results with intravitreal aflibercept injection vs. sham in moderately severe to severe nonproliferative diabetic retinopathy.
A higher rate of complications in the group that switched to as-needed dosing in the second year suggest that that regimen may lead to undertreatment in some cases.
The PANORAMA study involved 402 patients with nonproliferative diabetic retinopathy without diabetic macular edema. In the active treatment arms, patients were randomly assigned to receive, after completion of a loading phase, either

Full Story →